bovnews3h
Trevi Therapeutics Inc (TRVI) Stock Rated Outperform by Leerink Partners
Notable insider trades include GOOD JENNIFER L, President & CEO at Trevi Therapeutics Inc (TRVI), who sold 40277 shares on Sep 05 ’24, at $3.11 each, totaling $0.13 million. On May 29 ’24, SCIASCIA ...
FiercePharma46m
In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines
With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...
Align Technology Misses Third-Quarter Revenue Estimates on Weaker Demand for Teeth Aligners
Align Technology missed Wall Street estimates for third-quarter revenue on Wednesday, on lower-than-expected demand for its clear teeth aligners among younger patients. Shares of the company were down ...
Leerink Partnrs Issues Positive Estimate for Opthea Earnings
Analysts at Leerink Partnrs lifted their FY2025 EPS estimates for shares of Opthea in a report released on Tuesday, October ...
Mind Medicine assumed with an Outperform at Leerink
Leerink assumed coverage of Mind Medicine with an Outperform rating and $20 price target The firm likes the emerging ...
Nasdaq28d
Leerink Partners Initiates Coverage of Voyager Therapeutics (VYGR) with Outperform Recommendation
Fintel reports that on October 16, 2024, Leerink Partners initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a Outperform recommendation. As of September 25, 2024, the average one ...
Leerink Partnrs Has Negative Outlook of Biohaven Q3 Earnings
Research analysts at Leerink Partnrs cut their Q3 2024 earnings per share (EPS) estimates for Biohaven in a report released ...
Leerink Partners' Affiliate, MEDACorp, Launches the Center for Pharmacoeconomics to Evaluate the Societal Impact of Healthcare Treatments
Leerink Partners' affiliate, MEDACorp, announced today the launch of a new division, the Center for Pharmacoeconomics (CPE), which will be dedicated to advancing the understanding of the societal ...